ATEZOLIZUMAB + Doxorubicin hydrochloride for sarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Jul 2025: Trial registered, NCT07049848
  2. 11 Sep 2025: Trial started, NCT07049848

The trials

NCT07049848: SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

State
Under way
Phase
Phase 2
People
50 planned
Started
11 Sep 2025
Primary completion
1 Jan 2028
Arms
Phase II Treatment with Neo-Adju Chemo/Radiation/Surgery/Adju Chemo
Results
None posted
  1. 3 Jul 2025: Trial registered
  2. 11 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.